Evista, Raloxifene Newswire

Evista, Raloxifene Newswire

Comprehensive Real-Time News Feed for Evista, Raloxifene (generic).

Results 1 - 20 of 30 in Evista, Raloxifene (generic)

  1. Neurocognitive, Neuroprotective, and Cardiometabolic Effects of...Read the original story

    May 22, 2016 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. Raloxifene is a selective estrogen receptor modulator that has been approved for treating osteoporosis and breast cancer in high-risk postmenopausal women.

    Comment?

  2. Eli Lilly Warns of Job Cuts at Irish PlantRead the original story

    May 2, 2016 | BioSpace

    One of Ireland's largest pharmaceutical companies has warned of job losses at its Kinsale plant if the EU does not exempt it from a forthcoming ban on a carcinogenic chemical. Eli Lilly, a US multinational with 800 employees in Ireland, uses the chemical to produce raloxifene, marketed as Evista, a prescription drug to prevent osteoporosis in post-menopausal women.

    Comment?

  3. Association between gastrointestinal events and osteoporosis...Read the original story w/Photo

    Apr 29, 2016 | BioMed Central

    A substantial portion of women diagnosed with osteoporosis do not initiate pharmacotherapy to reduce fracture risk. In clinical practice, gastrointestinal events have been linked with OP therapy discontinuation.

    Comment?

  4. Response of bone turnover markers to raloxifene treatment in postmenopausal women with osteopenia.Read the original story

    Apr 28, 2016 | CiteULike

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA We used two methods of identifying women who reached the target for raloxifene treatment with bone turnover markers. Both approaches identified women that responded to treatment but did not fully agree and may be complementary.

    Comment?

  5. Canadian Pharmacy Announces the Generic Cancer Drugs ProgramRead the original story w/Photo

    Mar 26, 2015 | 24-7 Press Release

    NationDrugs.to announces that cancer patients now have more access to more affordable medications through its International Generics Program CANADA, March 27, 2015 /24-7PressRelease/ -- NationDrugs.to the premier Canadian pharmacy intermediary since 2002 highlights the need to help cancer patients find access to more affordable cancer medications. The Wall Street Journal featured an article in February 2015 about Hagop Kantarjian discussing his concern for the affordability of cancer drugs.

    Comment?

  6. Sermonix To Give Lasofoxifene Oral Presentation AtRead the original story

    Mar 31, 2016 | BioSpace

    Sermonix Pharmaceuticals LLC, a specialty pharmaceutical company focused on the development and commercialization of emerging late-stage women's health products, announced today it will deliver an oral presentation related to its investigational drug, lasofoxifene, at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Disease on April 15. The meeting, held at the Palacio de Ferias y Congresos de Malaga in Malaga, Spain, will feature Sermonix's presentation: "The Phase 3 Comparison of Raloxifene and Lasofoxifene Trial: Changes in Bone Markers and Bone Mineral Density." "Osteoporosis is a serious public health concern in developed countries including within Europe.

    Comment?

  7. Canadian Pharmacy Announces the Generic Cancer Drugs ProgramRead the original story w/Photo

    Mar 26, 2015 | 24-7 Press Release

    NationDrugs.to announces that cancer patients now have more access to more affordable medications through its International Generics Program CANADA, March 27, 2015 /24-7PressRelease/ -- NationDrugs.to the premier Canadian pharmacy intermediary since 2002 highlights the need to help cancer patients find access to more affordable cancer medications. The Wall Street Journal featured an article in February 2015 about Hagop Kantarjian discussing his concern for the affordability of cancer drugs.

    Comment?

  8. Canadian Pharmacy Announces the Generic Cancer Drugs ProgramRead the original story w/Photo

    Mar 27, 2015 | 24-7 Press Release

    NationDrugs.to announces that cancer patients now have more access to more affordable medications through its International Generics Program CANADA, March 27, 2015 /24-7PressRelease/ -- NationDrugs.to the premier Canadian pharmacy intermediary since 2002 highlights the need to help cancer patients find access to more affordable cancer medications. The Wall Street Journal featured an article in February 2015 about Hagop Kantarjian discussing his concern for the affordability of cancer drugs.

    Comment?

  9. Canadian Pharmacy Announces the Generic Cancer Drugs ProgramRead the original story w/Photo

    Mar 27, 2015 | 24-7 Press Release

    NationDrugs.to announces that cancer patients now have more access to more affordable medications through its International Generics Program CANADA, March 27, 2015 /24-7PressRelease/ -- NationDrugs.to the premier Canadian pharmacy intermediary since 2002 highlights the need to help cancer patients find access to more affordable cancer medications. The Wall Street Journal featured an article in February 2015 about Hagop Kantarjian discussing his concern for the affordability of cancer drugs.

    Comment?

  10. Canadian Pharmacy Announces the Generic Cancer Drugs ProgramRead the original story w/Photo

    Mar 27, 2015 | 24-7 Press Release

    NationDrugs.to announces that cancer patients now have more access to more affordable medications through its International Generics Program CANADA, March 27, 2015 /24-7PressRelease/ -- NationDrugs.to the premier Canadian pharmacy intermediary since 2002 highlights the need to help cancer patients find access to more affordable cancer medications. The Wall Street Journal featured an article in February 2015 about Hagop Kantarjian discussing his concern for the affordability of cancer drugs.

    Comment?

  11. Canadian Pharmacy Announces the Generic Cancer Drugs ProgramRead the original story w/Photo

    Mar 27, 2015 | 24-7 Press Release

    NationDrugs.to announces that cancer patients now have more access to more affordable medications through its International Generics Program CANADA, March 27, 2015 /24-7PressRelease/ -- NationDrugs.to the premier Canadian pharmacy intermediary since 2002 highlights the need to help cancer patients find access to more affordable cancer medications. The Wall Street Journal featured an article in February 2015 about Hagop Kantarjian discussing his concern for the affordability of cancer drugs.

    Comment?

  12. Women may have better flu defensesRead the original story w/Photo

    Jan 18, 2016 | PhysOrg Weblog

    The female sex hormone estrogen has anti-viral effects against the influenza A virus, commonly known as the flu, a new study in American Journal of Physiology-Lung Cellular and Molecular Physiology reports. A virus infects and causes sickness by entering a cell and making copies of itself inside the host cell.

    Comment?

  13. 'Man Flu' Explains Why Men May Be The Weaker SexRead the original story w/Photo

    Jan 14, 2016 | MSN Healthy Living

    A sick man's pain, aches, and groans might be thought of as nothing more than incessant whining, a phenomenon known as " man flu ." However, a recent study has uncovered men are the weaker sex when it comes to health.

    Comment?

  14. Battle Of The Sexes: Female Sex Hormone Weakens Flu Virus For Women, Not MenRead the original story w/Photo

    Jan 14, 2016 | Medical Daily

    A sick man's pain, aches, and groans might be thought of as nothing more than incessant whining, a phenomenon known as " man flu ." However, a recent study has uncovered men are the weaker sex when it comes to health.

    Comment?

  15. Estrogen may weaken flu virus in womenRead the original story w/Photo

    Jan 13, 2016 | Medical News Today

    A new study may explain why flu appears to hit men harder than women. Researchers who tested various forms of the female sex hormone estrogen - which is also present in men - on nasal cells from men and women, found the compounds reduced virus replication in the female but not the male cells.

    Comment?

  16. Estrogen may protect women against fluRead the original story w/Photo

    Jan 12, 2016 | Medical News

    The female sex hormone estrogen has anti-viral effects against the influenza A virus, commonly known as the flu, a new study in American Journal of Physiology - Lung Cellular and Molecular Physiology reports. A virus infects and causes sickness by entering a cell and making copies of itself inside the host cell.

    Comment?

  17. Estrogen Protects Women Against the Flu, Study FindsRead the original story

    Jan 12, 2016 | Infection Control Today

    The female sex hormone estrogen has antiviral effects against the influenza A virus, a new study in American Journal of Physiology - Lung Cellular and Molecular Physiology reports. A virus infects and causes sickness by entering a cell and making copies of itself inside the host cell.

    Comment?

  18. Not the Weaker Sex: Estrogen Protects Women Against the Flu, Study FindsRead the original story w/Photo

    Jan 11, 2016 | Newswise

    The female sex hormone estrogen has anti-viral effects against the influenza A virus, commonly known as the flu, a new study in American Journal of Physiology-Lung Cellular and Molecular Physiology reports. A virus infects and causes sickness by entering a cell and making copies of itself inside the host cell.

    Comment?

  19. Strong Pipeline to Drive Global Women's Health Therapeutics Market, Says Transparency Market ResearchRead the original story w/Photo

    Dec 31, 2015 | SBWire

    The presence of several leading pharmaceutical companies in the development of women's health therapeutics is a key factor driving the global market, states Transparency Market Research in its latest report. This research study is titled "Women's Health Therapeutics Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecasts 2011 - 2017" and is backed by unbiased, accurate, and valuable information.

    Comment?

  20. Researchers use gene therapy to extend estrogen's protective effects on memoryRead the original story w/Photo

    Dec 8, 2015 | PhysOrg Weblog

    The hormone estrogen helps protect memory and promote a healthy brain, but this effect wanes as women age, and even estrogen replacement therapy stops working in humans after age 65. Now researchers at University of Florida Health have used gene therapy in a rat model to show that the expression of a particular receptor can reinstate lost memory function. The scientists, including Thomas C. Foster, Ph.D., a professor of neuroscience and the Evelyn F. McKnight chair for research on cognitive aging, and Linda A. Bean, Ph.D., report their findings in the current edition of The Journal of Neuroscience .

    Comment?